Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome. [electronic resource]
Producer: 20131210Description: 743-4 p. digitalISSN:- 1499-2752
- Antirheumatic Agents -- therapeutic use
- Child
- Dose-Response Relationship, Drug
- Drug Substitution
- Drug Therapy, Combination
- Female
- Humans
- Immunosuppressive Agents -- therapeutic use
- Interleukin 1 Receptor Antagonist Protein -- therapeutic use
- Macrophage Activation Syndrome -- drug therapy
- Remission Induction
- Treatment Failure
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.